HeraMED Secures $115K US Pilot with Lee Health to Monitor 2,000 Pregnancies
HeraMED has secured a pilot agreement with Lee Health, a leading US non-profit health system, to trial its HeraCARE digital maternity platform, aiming to transform prenatal and postpartum care through remote monitoring and virtual engagement.
- Pilot agreement signed with Lee Health, a $3B Florida health system
- HeraCARE platform to support prenatal and postpartum remote monitoring
- Pilot valued at USD 115,000, running 3 to 6 months starting December 2025
- Phase 2 scale-up planned to cover 2,000 pregnancies annually
- Integration with Lee Health’s Epic electronic medical record system
A Strategic US Partnership
HeraMED Limited, an Australian digital health innovator, has taken a significant step into the US market by partnering with Lee Health, a major non-profit healthcare provider in Southwest Florida. Lee Health, with its $3 billion revenue and reputation for excellence in maternity care, will pilot HeraMED’s HeraCARE platform, a next-generation digital maternity solution designed to enhance patient engagement and remote monitoring during pregnancy.
Pilot Program Details and Goals
The pilot, commencing in December 2025, will run for a minimum of three months and up to six months. It involves onboarding pregnant women across multiple customized care plans that cover prenatal and postpartum stages. HeraCARE kits, including HeraBEAT fetal heart rate monitors and connected blood pressure cuffs, will enable real-time remote monitoring. Key performance indicators such as patient engagement, virtual visits, and remote monitoring effectiveness will be closely evaluated alongside the integration roadmap with Lee Health’s Epic electronic medical record system.
Potential for Scalable Expansion
Success in this pilot could lead to a full-scale deployment supporting up to 2,000 pregnancies annually within Lee Health’s network. This phased approach allows both parties to optimize workflows, demonstrate clinical and economic value, and align on a commercial model. The pilot’s USD 115,000 value covers implementation, logistics, patient onboarding, and ongoing technical support, setting the stage for a broader rollout.
Industry Implications
HeraMED’s collaboration with a top-tier US health system underscores the growing demand for digital transformation in maternity care. By leveraging cloud computing, AI, and connected devices, HeraCARE aims to reshape how expectant mothers and healthcare providers interact, potentially improving outcomes and reducing costs. Lee Health’s leadership highlights the importance of innovation that enhances patient experience and care quality, signaling a promising future for hybrid maternity care models.
Looking Ahead
As the pilot unfolds, HeraMED will monitor key milestones and share progress updates, with investors and industry watchers keen to see if this partnership can unlock scalable digital maternity care solutions in the US market. The outcome could influence broader adoption trends and competitive dynamics in healthcare technology.
Bottom Line?
HeraMED’s US pilot with Lee Health could be the catalyst for widespread digital maternity care adoption, but success hinges on delivering measurable clinical and operational benefits.
Questions in the middle?
- Will HeraCARE’s integration with Epic EMR meet Lee Health’s clinical workflow needs?
- How will patient engagement and clinical outcomes compare to traditional maternity care?
- What commercial terms and pricing will HeraMED pursue post-pilot for large-scale deployment?
